PT828494E - Compostos farmaceuticos - Google Patents
Compostos farmaceuticosInfo
- Publication number
- PT828494E PT828494E PT95922148T PT95922148T PT828494E PT 828494 E PT828494 E PT 828494E PT 95922148 T PT95922148 T PT 95922148T PT 95922148 T PT95922148 T PT 95922148T PT 828494 E PT828494 E PT 828494E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical compounds
- methyl
- benzodiazepine
- thieno
- piperazinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Processing Of Meat And Fish (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Percussion Or Vibration Massage (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Light Receiving Elements (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/006859 WO1996038151A1 (en) | 1995-05-30 | 1995-05-30 | Method for treating cognitive dysfunction |
CA002219902A CA2219902A1 (en) | 1995-05-30 | 1995-05-30 | Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
PT828494E true PT828494E (pt) | 2002-10-31 |
Family
ID=25679786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95922148T PT828494E (pt) | 1995-05-30 | 1995-05-30 | Compostos farmaceuticos |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0828494B1 (pt) |
JP (1) | JPH11506096A (pt) |
AT (1) | ATE220550T1 (pt) |
AU (1) | AU707858B2 (pt) |
CZ (1) | CZ292565B6 (pt) |
DE (1) | DE69527442T2 (pt) |
DK (1) | DK0828494T3 (pt) |
ES (1) | ES2180643T3 (pt) |
FI (1) | FI973987A (pt) |
HK (1) | HK1009393A1 (pt) |
HU (1) | HUT77907A (pt) |
MX (1) | MX9707936A (pt) |
NO (1) | NO318553B1 (pt) |
NZ (1) | NZ288037A (pt) |
PL (1) | PL189714B1 (pt) |
PT (1) | PT828494E (pt) |
WO (1) | WO1996038151A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
UA57727C2 (uk) * | 1996-03-11 | 2003-07-15 | Елі Ліллі Енд Компані | Спосіб лікування надмірної агресивності |
PL196814B1 (pl) * | 2002-05-17 | 2008-02-29 | Inst Farmaceutyczny | Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty |
DE602005027308D1 (de) | 2004-01-27 | 2011-05-19 | Synthon Bv | Stabile salze von olanzapin |
EP1838716B1 (en) | 2005-01-05 | 2011-06-01 | Eli Lilly And Company | Olanzapine pamoate dihydrate |
PL381564A1 (pl) | 2007-01-22 | 2008-08-04 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270464A (en) * | 1989-03-14 | 1993-12-14 | Janssen Pharmaceutica N.V. | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1995
- 1995-05-30 AU AU26936/95A patent/AU707858B2/en not_active Ceased
- 1995-05-30 PL PL95323785A patent/PL189714B1/pl not_active IP Right Cessation
- 1995-05-30 EP EP95922148A patent/EP0828494B1/en not_active Expired - Lifetime
- 1995-05-30 CZ CZ19973243A patent/CZ292565B6/cs not_active IP Right Cessation
- 1995-05-30 PT PT95922148T patent/PT828494E/pt unknown
- 1995-05-30 WO PCT/US1995/006859 patent/WO1996038151A1/en active IP Right Grant
- 1995-05-30 AT AT95922148T patent/ATE220550T1/de not_active IP Right Cessation
- 1995-05-30 HU HU9801173A patent/HUT77907A/hu not_active Application Discontinuation
- 1995-05-30 DE DE69527442T patent/DE69527442T2/de not_active Expired - Fee Related
- 1995-05-30 NZ NZ288037A patent/NZ288037A/en unknown
- 1995-05-30 MX MX9707936A patent/MX9707936A/es not_active IP Right Cessation
- 1995-05-30 DK DK95922148T patent/DK0828494T3/da active
- 1995-05-30 JP JP8536420A patent/JPH11506096A/ja active Pending
- 1995-05-30 ES ES95922148T patent/ES2180643T3/es not_active Expired - Lifetime
-
1997
- 1997-10-15 NO NO19974766A patent/NO318553B1/no unknown
- 1997-10-17 FI FI973987A patent/FI973987A/fi not_active IP Right Cessation
-
1998
- 1998-08-26 HK HK98110242A patent/HK1009393A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69527442D1 (de) | 2002-08-22 |
EP0828494A4 (en) | 1999-11-24 |
WO1996038151A1 (en) | 1996-12-05 |
DE69527442T2 (de) | 2003-02-20 |
ES2180643T3 (es) | 2003-02-16 |
HK1009393A1 (en) | 1999-06-04 |
DK0828494T3 (da) | 2002-09-02 |
CZ324397A3 (cs) | 1998-08-12 |
ATE220550T1 (de) | 2002-08-15 |
PL189714B1 (pl) | 2005-09-30 |
AU2693695A (en) | 1996-12-18 |
NO318553B1 (no) | 2005-04-11 |
JPH11506096A (ja) | 1999-06-02 |
CZ292565B6 (cs) | 2003-10-15 |
AU707858B2 (en) | 1999-07-22 |
NZ288037A (en) | 1999-09-29 |
NO974766D0 (no) | 1997-10-15 |
NO974766L (no) | 1997-12-09 |
MX9707936A (es) | 1997-12-31 |
EP0828494A1 (en) | 1998-03-18 |
PL323785A1 (en) | 1998-04-27 |
EP0828494B1 (en) | 2002-07-17 |
FI973987A0 (fi) | 1997-10-17 |
FI973987A (fi) | 1997-10-17 |
HUT77907A (hu) | 1998-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY114701A (en) | Process and crystal forms of 2-methyl-thieno- benzodiazepine | |
SI1513846T1 (sl) | Postopek za pripravo olanzapina form I | |
ZA963098B (en) | Method for treating dyskinesias. | |
NZ510208A (en) | Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt | |
TR199600779A2 (tr) | Imidazo benzodiazepin türevlerinin imal edilmesine mahsus yöntem. | |
PT828494E (pt) | Compostos farmaceuticos | |
DK0733634T3 (da) | Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat | |
NO982911L (no) | FremgangsmÕte for behandling av depresjon | |
TW429149B (en) | Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine | |
EP0911028A3 (en) | Method for treating sexual dysfunction | |
NZ332037A (en) | Olanzapine for treating migraine pain | |
DK0831835T3 (da) | Behandling af anorexia | |
ZA976854B (en) | Treatment of psychotic disorders. | |
NO983006L (no) | Fremgangsmåte for aminokarbonylering av benzazepiner og benzodiazepiner | |
HUP9902882A2 (hu) | Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására | |
ECSP961694A (es) | Procedimeinto para preparar olanzapina (caso x - 9992m) | |
JO1926B1 (en) | The process of forming crystalline forms of 2- methyl tinzo benzodiazepine |